Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become the most common causes of liver disease in children and adolescents. Although several reports have confirmed the significant correlation between NAFLD and growth hormone (GH)-insulin-like growth factor 1(IGF-1) axis, no study further i...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jiang, Liang, Shuang, Ma, Jiahui, Xiao, Yanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881210/
https://www.ncbi.nlm.nih.gov/pubmed/35216556
http://dx.doi.org/10.1186/s12902-022-00967-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881210/
https://www.ncbi.nlm.nih.gov/pubmed/35216556
http://dx.doi.org/10.1186/s12902-022-00967-y

Ejemplares similares